Bill Avery

Bill Avery has a extensive work experience in the biopharmaceutical industry, spanning multiple companies and roles. Bill is currently the SVP, Translational Development at Kisbee Therapeutics since October 2021. Prior to this, they worked as the Senior Vice President, Nonclinical Development at Xilio Therapeutics, Inc. from June 2021 to September 2021. From September 2019 to January 2021, they served as the Vice President, Preclinical at Lyndra Therapeutics. Before that, they were the Vice President of Preclinical and Translational Development at Life Biosciences from January 2018 to August 2019. Their work also includes being the Vice President Translational Development at Momenta Pharmaceuticals from January 2009 to December 2017 and the Director- Pharmacology at CombinatoRx, Inc. from January 2002 to March 2009.

Bill Avery attended the University of Massachusetts Amherst without completing a specific degree program or field of study.